T1	Gene_or_protein	14 29	tyrosine kinase
T2	Chemical	14 40	tyrosine kinase inhibitors
T3	Chemical	43 47	TKIs
T4	Chemical	50 59	gefitinib
T5	Chemical	64 77	erlotinib are
T6	Disease	91 134	non-small cell lung cancers ( NSCLCs ) with
T7	Limited_variation	135 193	epidermal growth factor receptor ( EGFR ) gene mutations .
R1	influences	Arg1:T1	Arg2:T2
R2	decreases	Arg1:T1	Arg2:T3
R3	treats	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	treats	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T1	Arg2:T7
R7	decreases	Arg1:T2	Arg2:T1
R8	isEquivalentTo	Arg1:T2	Arg2:T3
R9	treats	Arg1:T2	Arg2:T4
R10	treats	Arg1:T2	Arg2:T5
R11	treats	Arg1:T2	Arg2:T6
R12	treats	Arg1:T2	Arg2:T7
R13	isEquivalentTo	Arg1:T3	Arg2:T1
R14	isEquivalentTo	Arg1:T3	Arg2:T2
R15	influences	Arg1:T3	Arg2:T4
R16	treats	Arg1:T3	Arg2:T5
R17	treats	Arg1:T3	Arg2:T6
R18	isAssociatedWith	Arg1:T3	Arg2:T7
R19	influences	Arg1:T4	Arg2:T1
R20	influences	Arg1:T4	Arg2:T2
R21	influences	Arg1:T4	Arg2:T3
R22	treats	Arg1:T4	Arg2:T5
R23	treats	Arg1:T4	Arg2:T6
R24	isAssociatedWith	Arg1:T4	Arg2:T7
R25	influences	Arg1:T5	Arg2:T1
R26	influences	Arg1:T5	Arg2:T2
R27	influences	Arg1:T5	Arg2:T3
R28	influences	Arg1:T5	Arg2:T4
R29	treats	Arg1:T5	Arg2:T6
R30	isAssociatedWith	Arg1:T5	Arg2:T7
R31	isAssociatedWith	Arg1:T6	Arg2:T1
R32	isAssociatedWith	Arg1:T6	Arg2:T2
R33	isAssociatedWith	Arg1:T6	Arg2:T3
R34	isAssociatedWith	Arg1:T6	Arg2:T4
R35	isAssociatedWith	Arg1:T6	Arg2:T5
R36	isAssociatedWith	Arg1:T6	Arg2:T7
R37	isAssociatedWith	Arg1:T7	Arg2:T1
R38	isAssociatedWith	Arg1:T7	Arg2:T2
R39	isAssociatedWith	Arg1:T7	Arg2:T3
R40	isAssociatedWith	Arg1:T7	Arg2:T4
R41	isAssociatedWith	Arg1:T7	Arg2:T5
R42	isAssociatedWith	Arg1:T7	Arg2:T6
